Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous Bornavirus-like nucleoprotein 3, pseudogene (EBLN3P) is a pseudogene-derived long non-coding RNA found in the human genome[1][5]. Unlike protein-coding genes, pseudogenes like EBLN3P do not produce functional proteins but can regulate gene expression through RNA-mediated mechanisms[2]. Recent research indicates that EBLN3P is upregulated in osteosarcoma, where it acts as a competitive endogenous RNA (ceRNA), sponging microRNA miR-224-5p and modulating Rab10 expression, ultimately promoting tumor cell proliferation, migration, and invasion[2]. Although EBLN3P has no direct links as a therapeutic target or drug interactor, its regulatory role in cancer biology makes it a research interest for future diagnostic or prognostic approaches[2][5]. This molecule is best classified as a pseudogene-derived long non-coding RNA involved in cancer-related gene regulation, not as a classical drug target or receptor[2][5].
Not applicable; drugs do not target EBLN3P. Mechanistically, EBLN3P acts as a sponge for microRNAs (e.g., miR-224-5p) affecting gene expression networks related to cancer progression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous Bornavirus-like nucleoprotein 3, pseudogene (EBLN3P).